![Markus Skog Olsson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Markus Skog Olsson
Directeur/Membre du Conseil chez
Balticgruppen Bio AB
Health Technology
Profil
Markus Skog Olsson is currently a Director at Balticgruppen Bio AB. He was previously a Director at Betagenon Sweden AB.
Postes actifs de Markus Skog Olsson
| Sociétés | Poste | Début |
|---|---|---|
Balticgruppen Bio AB
 Balticgruppen Bio AB Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops activated protein kinase | Directeur/Membre du Conseil | - |
Anciens postes connus de Markus Skog Olsson
| Sociétés | Poste | Fin |
|---|---|---|
Betagenon Sweden AB
 Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Betagenon Sweden AB
Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases | Health Technology |
Balticgruppen Bio AB
Balticgruppen Bio AB Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops activated protein kinase | Health Technology |
